Group One Trading
CYTO

Group One Trading’s Altamira Therapeutics Ltd CYTO Stock Holding History

Group One Trading’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed -$3K – 9037
2021
Q3 		$3K Sell
4
-64
-94% -$72.1K ﹤0.01% 7909
2021
Q2 		$97K Buy
68
+50
+278% +$68.6K ﹤0.01% 5997
2021
Q1 		$25K Buy
+18
New +$24.1K ﹤0.01% 6666
2017
Q1 		– Hold
0
– -$1K – 5112
2016
Q4 		– Hold
0
– – – 4334

Other funds holding CYTO

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's CYTO Position: Q4 2024 in Review

Group One Trading sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2024, closing a stake of 14 shares — an estimated $9 sold.

Group One Trading first reported a position in CYTO in Q1 2021 and held it in 14 quarters. The position peaked at $94K in Q4 2021. 2 funds tracked by Wall St. Rank hold CYTO as of Q4 2024.

  • Group One Trading reported no remaining Altamira Therapeutics Ltd position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 14 Altamira Therapeutics Ltd shares in Q4 2024, an estimated $9.
  • Group One Trading first reported a position in Altamira Therapeutics Ltd in Q1 2021 and held it in 14 quarters.
  • Group One Trading's Altamira Therapeutics Ltd position peaked at $94K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.